TargED Biopharmaceuticals B.V.

About the company

TargED Biopharmaceuticals B.V. is a clinical-stage biotechnology company focused on developing innovative targeted therapies for thrombotic and cardiovascular diseases. The company is advancing precision medicines designed to dissolve harmful blood clots while minimizing damage to healthy tissues, with the goal of improving outcomes for patients experiencing life-threatening vascular conditions. Through cutting-edge scientific research, strategic collaborations, and a commitment to innovation, TargED Biopharmaceuticals B.V. is dedicated to addressing significant unmet medical needs and transforming the treatment of thrombotic diseases with safer and more effective therapeutic solutions.